Scribd Logo
Upload

Welcome to Scribd!

  • 30 views

    Drug Study Drug Name: Ceftriaxone A. Classification

    Uploaded by

    Mark Bareng
    This document summarizes information about the antibiotic drug Ceftriaxone. It is a third generation cephalosporin antibiotic used to treat bacterial infections. It works by binding to bacterial cell membranes and inhibiting cell wall synthesis, which disrupts the cell wall and kills the bacteria. Nurses are responsible for monitoring the patient and injection sites for signs of adverse reactions or lack of treatment effectiveness and educating patients and their families on proper administration and prevention of infection spread.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Drug Study Drug Name: Ceftriaxone A. Classification

    Uploaded by

    Mark Bareng
    30 views2 pages
    This document summarizes information about the antibiotic drug Ceftriaxone. It is a third generation cephalosporin antibiotic used to treat bacterial infections. It works by binding to bacterial cell membranes and inhibiting cell wall synthesis, which disrupts the cell wall and kills the bacteria. Nurses are responsible for monitoring the patient and injection sites for signs of adverse reactions or lack of treatment effectiveness and educating patients and their families on proper administration and prevention of infection spread.

    Original Title

    Ceftriaxone

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes information about the antibiotic drug Ceftriaxone. It is a third generation cephalosporin antibiotic used to treat bacterial infections. It works by binding to bacterial cell membranes and inhibiting cell wall synthesis, which disrupts the cell wall and kills the bacteria. Nurses are responsible for monitoring the patient and injection sites for signs of adverse reactions or lack of treatment effectiveness and educating patients and their families on proper administration and prevention of infection spread.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    30 views2 pages

    Drug Study Drug Name: Ceftriaxone A. Classification

    Uploaded by

    Mark Bareng
    This document summarizes information about the antibiotic drug Ceftriaxone. It is a third generation cephalosporin antibiotic used to treat bacterial infections. It works by binding to bacterial cell membranes and inhibiting cell wall synthesis, which disrupts the cell wall and kills the bacteria. Nurses are responsible for monitoring the patient and injection sites for signs of adverse reactions or lack of treatment effectiveness and educating patients and their families on proper administration and prevention of infection spread.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    You are on page 1of 2

    Drug Study

    Drug name: Ceftriaxone

    A. Classification:

    General Classification – Antibiotic

    Specific Classification – Cephalosporin (third generation)

    B. Why the drug is given:

    This drug is given to treat susceptible infections that are caused by bacteria like infection of
    the intestinal tract.

    C. Mechanism of action:

    Ceftriaxone binds to bacterial cell membranes to inhibit cell wall synthesis. This cause
    disruption of the bacterial cell wall and leads to bacterial cell death.

    D. Desired effect:

     This drug is given to the patient to prevent the growth of bacterial infections that may
    develop.
     This drug is given to the patient to kill the bacterial infection that resides in its body.

    E. Nursing Responsibilities:

    Independent
     Inspect injection sites for induration and inflammation.
     To note IV injection sites for signs of phlebitis.
    Patient/Family-Related Instruction

     Continue to administer this medication until the full-prescribed amount is finished


    even if symptoms disappear after a few days.
     Stopping the medication too early may allow bacteria to continue to grow,
    which may result in a relapse of the infection and develop resistance to
    antibiotic.
     Instruct the patient to drink a lots of fluids and to maintain nutrition even though
    nausea and vomiting may occur.
     To keep the kidneys working properly while using it.
     Instruct the family to always wash hands thoroughly and disinfect equipment Use
    universal precautions or isolation procedures as indicated for specific patients.
     To help prevent the spread of infection.

    Dependent

     Monitor signs of pseudomembranous colitis, including diarrhea, abdominal pain,


    fever, pus or mucus in stools, and other severe or prolonged GI problems (nausea,
    vomiting, heartburn).  
     Notify physician if these reactions occur to prevent untoward complications.
     Monitor signs of petechiae, ecchymotic areas, epistaxis, or any unexplained bleeding.
     Notify physician immediately if these reactions occur. Ceftriaxone appears to
    alter vitamin K–producing gut bacteria therefore, hypoprothrombinemic
    bleeding may occur.
     Monitor signs of blood dyscrasias, including eosinophilia (fatigue, weakness,
    myalgia), hemolytic anemia (malaise, dizziness, jaundice,), leukopenia (fever, sore
    throat, mucosal lesions, signs of infection), or thrombocytosis (headache, dizziness,
    chest pain, fainting, visual disturbances, numbness or tingling in the hands and feet).
    Report this signs to the physician.
     Most patients with typhoid fever are moderately anemic.

     Monitor signs of allergic reactions and anaphylaxis, including pulmonary symptoms


    (tightness in the throat and chest, wheezing, cough dyspnea) or skin reactions (rash,
    pruritus, urticaria). Report this signs to the physician.
     This product may contain inactive ingredients, which can cause allergic
    reactions or other problems.
     Monitor injection site for pain, swelling, and irritation. Report prolonged or excessive
    injection site reactions to the physician.
     To avoid the risk of having skin problems.
    Interdependent
     Perform culture and sensitivity tests before initiation of therapy and periodically
    before therapy.
     To find the most effective antibiotic to kill an infecting microorganism.

    You might also like